pyrroles has been researched along with Adenocarcinoma, Follicular in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eilles, C; Grimm, D; Grosse, J; Magnusson, NE; Pietsch, J; Pohl, F; Warnke, E; Wehland, M; Wise, P | 1 |
| Baudin, E; Bonichon, F; Borget, I; Brassard, M; Chougnet, CN; Claude-Desroches, M; de la Fouchardière, C; Do Cao, C; Giraudet, AL; Leboulleux, S; Massicotte, MH; Schlumberger, M | 1 |
| Alonso, T; Díez, JJ; Grande, E; Iglesias, P | 1 |
| Barett, C; Bikas, A; Burman, KD; Clark, BG; Desale, S; Gandhi, R; Jelinek, JS; Kundra, P; Mete, M; O'Keefe, K; Wartofsky, L; Wexler, JA; Wray, L | 1 |
| Atallah, V; Bardet, S; Bonichon, F; De La Fouchardiere, C; Dierick-Galet, A; Do Cao, C; Godbert, Y; Hocquelet, A; Italiano, A; Leboulleux, S; Leduc, N; Zerdoud, S | 1 |
| Asselineau, J; Bournaud-Salinas, C; Caron, P; Catargi, B; Daste, A; de la Fouchardière, C; Delord, JP; Digue, L; Do Cao, C; Doussau, A; Gimbert, A; Klein, M; Nicolli-Sire, P; Pedenon, D; Picat, MQ; Pouessel, D; Ravaud, A; Rodien, P; Wemeau, JL | 1 |
| Fagin, JA; Pfister, DG; Tuttle, RM | 1 |
| Antonetti, R; Cignarelli, M; Costantino, E; Gerardi, AM; Landriscina, M; Maddalena, F; Natalicchio, MI; Piscazzi, A | 1 |
| Boni, G; Ferdeghini, M; Mariani, G; Monzani, F; Pasqualetti, G; Polini, A; Ricci, S; Tognini, S | 1 |
| Conus, NM; Dawson, SJ; Hicks, RJ; McArthur, G; Raleigh, JM; Rischin, D; Toner, GC | 1 |
2 trial(s) available for pyrroles and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma; Carcinoma, Papillary; Chemotherapy, Adjuvant; Diarrhea; Disease-Free Survival; Fatigue; Female; Hand-Foot Syndrome; Humans; Indoles; Iodine Radioisotopes; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Pyrroles; Radiotherapy; Sunitinib; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Angiogenesis Inhibitors; Bone Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Female; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Pyrroles; Sunitinib; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Treatment Outcome | 2017 |
8 other study(ies) available for pyrroles and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
Mechanisms of apoptosis in irradiated and sunitinib-treated follicular thyroid cancer cells.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; Inhibitor of Apoptosis Proteins; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Survivin; Thyroid Neoplasms | 2014 |
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Disease-Free Survival; Female; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Piperidines; Pleural Neoplasms; Protein-Tyrosine Kinases; Pyrroles; Quinazolines; Retrospective Studies; Sorafenib; Sunitinib; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome | 2014 |
Activity and safety of sunitinib in patients with advanced radioactive iodine-refractory differentiated thyroid carcinoma in clinical practice.
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Carcinoma, Papillary; Disease Progression; Female; Humans; Indoles; Male; Middle Aged; Pyrroles; Retrospective Studies; Sunitinib; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome | 2015 |
Activity and Safety of Sunitinib in Patients with Advanced Radioiodine Refractory Thyroid Carcinoma: A Retrospective Analysis of 57 Patients.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Papillary; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Pyrroles; Retrospective Studies; Sunitinib; Survival Rate; Thyroid Neoplasms; Treatment Outcome | 2016 |
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Medullary; Carcinoma, Papillary; Humans; Indoles; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Thyroid Neoplasms | 2010 |
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Carcinoma, Papillary; Cell Line, Tumor; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; MAP Kinase Signaling System; Oncogene Proteins, Fusion; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Pyrroles; ras Proteins; Sunitinib; Thyroid Neoplasms | 2012 |
Off-label use of sunitinib in patients with advanced, epithelial thyroid cancer: a retrospective analysis.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Neoplasm Metastasis; Off-Label Use; Protein-Tyrosine Kinases; Pyrroles; Retrospective Studies; Sunitinib; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome | 2012 |
Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Antineoplastic Agents; Blotting, Western; Carcinoma, Papillary; Humans; Immunohistochemistry; Indoles; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Thyroid Neoplasms | 2008 |